Frederic(@FredOrs) he has led the transformation of IMV(@imv_inc) into a leading clinical-stage immune-oncology company with world-class collaborators and a strong scientific foundation.
— Sachs Associates (@SachsAssociates) September 3, 2020
e-Meet Frederic at #Sachs_BEF
More info @ https://t.co/XI3zEYGyl2 pic.twitter.com/2IZnlVIGEA
